Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Proxor 100micrograms/dose / 6micrograms/dose inhaler
0302000C0BYAABX
|
Proxor (old) | Beclometasone dipropionate | Respiratory System | 3 |
|
Beclometasone 50micrograms/dose inhaler
0302000C0AAAAAA
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | 2 |
|
Pollenase Hayfever Relief for Adults 50microg/dose nsl spy
1202010C0BKACAA
|
Pollenase (Nasal) | Beclometasone dipropionate | Ear, Nose and Oropharynx | 2 |
|
Beclazone 100 inhaler
0302000C0BFABAB
|
Beclazone | Beclometasone dipropionate | Respiratory System | 1 |
|
Beclometasone 0.025% ointment 10% in White soft paraffin
1304000C0AACDCD
|
Beclometasone dipropionate (Topical) | Beclometasone dipropionate | Skin | 1 |
|
Beclometasone 100micrograms/dose breath actuated inhaler
0302000C0AAATAT
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | 1 |
|
Beclometasone 250micrograms/dose inhaler
0302000C0AAACAC
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | 1 |
|
AeroBec 100 Autohaler
0302000C0BEACAT
|
AeroBec | Beclometasone dipropionate | Respiratory System | No data available |
|
AeroBec 50 Autohaler
0302000C0BEAAAS
|
AeroBec | Beclometasone dipropionate | Respiratory System | No data available |
|
AeroBec Forte 250 Autohaler
0302000C0BEABAU
|
AeroBec | Beclometasone dipropionate | Respiratory System | No data available |
|
Asmabec 100 Clickhaler
0302000C0BIAEBJ
|
Asmabec | Beclometasone dipropionate | Respiratory System | No data available |
|
Asmabec 250 Clickhaler
0302000C0BIAFBK
|
Asmabec | Beclometasone dipropionate | Respiratory System | No data available |
|
Asmabec 50 Clickhaler
0302000C0BIADBI
|
Asmabec | Beclometasone dipropionate | Respiratory System | No data available |
|
Beclazone 100 Easi-Breathe inhaler
0302000C0BFAEAT
|
Beclazone | Beclometasone dipropionate | Respiratory System | No data available |
|
Beclazone 200 inhaler
0302000C0BFAGAR
|
Beclazone | Beclometasone dipropionate | Respiratory System | No data available |
|
Beclazone 250 Easi-Breathe inhaler
0302000C0BFAFAU
|
Beclazone | Beclometasone dipropionate | Respiratory System | No data available |
|
Beclazone 250 inhaler
0302000C0BFACAC
|
Beclazone | Beclometasone dipropionate | Respiratory System | No data available |
|
Beclazone 50 Easi-Breathe inhaler
0302000C0BFADAS
|
Beclazone | Beclometasone dipropionate | Respiratory System | No data available |
|
Beclazone 50 inhaler
0302000C0BFAAAA
|
Beclazone | Beclometasone dipropionate | Respiratory System | No data available |
|
Beclo-Aqua 50micrograms/dose nasal spray
1202010C0BEAAAA
|
Beclo-Aqua | Beclometasone dipropionate | Ear, Nose and Oropharynx | No data available |
|
Becloforte 250micrograms/dose inhaler
0302000C0BBAAAC
|
Becloforte | Beclometasone dipropionate | Respiratory System | No data available |
|
Becloforte 400microgram disks
0302000C0BBADAQ
|
Becloforte | Beclometasone dipropionate | Respiratory System | No data available |
|
Becloforte 400microgram disks with Diskhaler
0302000C0BBACAJ
|
Becloforte | Beclometasone dipropionate | Respiratory System | No data available |
|
Beclometasone 0.025% in Aqueous cream
1304000C0AACFCF
|
Beclometasone dipropionate (Topical) | Beclometasone dipropionate | Skin | No data available |
|
Beclometasone 0.025% in White soft paraffin
1304000C0AACHCH
|
Beclometasone dipropionate (Topical) | Beclometasone dipropionate | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.